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Glossary
Absorption-The transport of a chemical from the outer surface of the skin into both the skin and systemic circulation (including penetration, permeation, and resorption).
Acute exposure-Contact with a chemical that occurs once or for only a short period of time.
Cancer-Any one of a group of diseases that occurs when cells in the body become abnormal and grow or multiply out of control.
Contaminant-A chemical that is (1) unintentionally present within a neat substance or mixture at a concentration less than 1.0% or (2) recognized as a potential carcinogen and present within a neat substance or mixture at a concentration less than 0.1%.
Cutaneous (or percutaneous)-Referring to the skin (or through the skin).
Dermal-Referring to the skin.
Dermal contact-Contact with (touching) the skin.
Direct effects-Localized, non-immune-mediated adverse health effects on the skin, including corrosion, primary irritation, changes in skin pigmentation, and reduction/disruption of the skin barrier integrity, occurring at or near the point of contact with chemicals.
Immune-mediated responses-Responses mediated by the immune system, including allergic responses.
Sensitization-A specific immune-mediated response that develops following exposure to a chemical, which, upon re-exposure, can lead to allergic contact dermatitis (ACD) or other immune-mediated diseases such as asthma, depending on the site and route of re-exposure. Substance-A chemical.
Systemic effects-Systemic toxicity associated with skin absorption of chemicals after exposure of the skin. In addition, special appreciation is expressed to the following individuals for serving as independent, external reviewers and providing comments that contributed to the development or improvement of this document: 
Uses: Dioxathion is an organophosphate pesticide [HSDB 2009] . No data were identified to determine the volume of the pesticide currently or historically produced in the United States.
Purpose
This skin notation profile presents (1) a brief summary of epidemiological and toxicological data associated with skin contact with dioxathion and (2) the rationale behind the hazard-specific skin notation (SK) assignment for dioxathion. The SK assignment is based on the scientific rationale and logic outlined in the Current Intelligence Bulletin (CIB) 61: A Strategy for Assigning New NIOSH Skin Notations [NIOSH 2009 ]. The summarized information and health hazard assessment are limited to an evaluation of the potential health effects of dermal exposure to dioxathion. A literature search was conducted through February 2013 to identify information on dioxathion, including but not limited to data relating to its toxicokinetics, acute toxicity, repeated-dose systemic toxicity, carcinogenicity, biological system/function-specific effects (including reproductive and developmental effects and immunotoxicity), irritation, and sensitization. Information was considered from studies of humans, animals, or appropriate modeling systems that are relevant to assessing the effects of dermal exposure to dioxathion. 
Overview of SK Assignment
Dioxathion is potentially capable of causing numerous adverse health effects following skin contact. A critical review of available data has resulted in the following SK assignment for dioxathion: SK: SYS (FATAL). Table 1 provides an overview of the critical effects and data used to develop the SK assignment for dioxathion. 
Systemic Toxicity from Skin Exposure (SK: SYS)
No toxicokinetic studies were identified in humans or in animals that estimated the degree of absorption of dioxathion through the skin following dermal exposure. The potential of dioxathion to pose a skin absorption hazard was evaluated, with use of a predictive algorithm for estimating and evaluating the health hazards of dermal exposure to substances [NIOSH 2009 ]. The evaluation method compares an estimated dose accumulated in the body from skin absorption and an estimated dose from respiratory absorption associated with a reference occupational exposure limit. On the basis of this algorithm, a ratio of the skin dose to the inhalation dose (SI ratio) of 0.0027 was calculated for dioxathion. An SI ratio of ≥0.1 indicates that a chemical is capable of producing systemic toxicity from skin exposure [NIOSH 2009 ]; therefore, dioxathion is not considered to be absorbed through the skin following dermal exposure. Additional information on the SI ratio and the variables used in its calculation are included in the appendix.
No estimates of the dermal lethal dose (LD Lo ) of dioxathion for humans were identified. However, acute dermal LD 50 values (the dose resulting in 50% mortality in the exposed animals) of 63 and 235 milligrams per kilogram body weight (mg/kg) were reported in female and male rats, respectively, when dioxathion was applied in xylene [Gaines 1969 ]. The dermal LD 50 value for m-xylene, for which data were available, is 14.1 millilitres per kilogram body weight (mL/kg, corresponding to 12,126 mg/kg) in rabbits [Smyth et al. 1960] , indicating that the observed value for dioxathion was not due to xylene toxicity. In rabbits, dermal LD 50 values for a commercial preparation of dioxathion containing 70% cis and trans isomers (present in the ratio of 1:2, respectively) were reported as 106 mg/kg in the absence of a solvent and 100 mg/kg applied in xylene as a solvent in rabbits and 63 and 235 mg/kg of the commercial preparation of dioxathion applied in xylene in female and male rats, respectively [Frawley et al. 1963 No designation NTP [2014] No designation USEPA [2015] No designation European Parliament [2008] No GHS designation IARC [2012] No designation EC [2013] No toxicokinetic data in humans or animals were identified that evaluated the potential of dioxathion to be absorbed through the skin following dermal exposure. Although a predictive model indicates that dioxathion has low potential to be absorbed through the skin and be systemically available, acute dermal toxicity studies in rats and rabbits [Frawley et al. 1963; Gaines 1969 ] 1 indicate dioxathion is absorbed through the skin, is systemically available, and can be fatal at low doses. Therefore, on the basis of the data for this assessment, dioxathion is assigned the SK: SYS (FATAL) notation.
Direct Effects on Skin (SK: DIR)
No human or animal in vivo studies that evaluated the corrosivity of dioxathion or in vitro tests for corrosivity using human or animal skin models or in vitro tests of skin integrity using cadaver skin were identified. No case reports or clinical studies or standard skin irritation tests were identified that evaluated the potential of dioxathion to cause skin irritation. The lack of in vitro tests, case reports or standard skin irritation tests precludes adequate evaluation of the potential of dioxathion to produce direct effects on the skin. Therefore, on the basis of the data for this assessment, dioxathion is not assigned the SK: DIR (IRR) notation. 
Immune-mediated Responses (SK: SEN)
Studies that evaluated skin sensitization following dermal exposure to dioxathion were not identified. No reports of sensitization in humans or predictive tests (for example, guinea pig maximization tests, Buehler tests, murine local lymph node assays, mouse ear swelling tests) or other tests that evaluated the potential of dioxathion to cause skin sensitization in animals were identified. The lack of diagnostic tests in humans and predictive tests in animals precludes adequate evaluation of the potential of dioxathion to cause skin sensitization. Therefore, on the basis of the data for this assessment, dioxathion is not assigned the SK: SEN notation.
Summary
No toxicokinetic data in humans or animals, or case reports, epidemiological studies or repeated dose, subchronic or chronic toxicity studies in animals were identified that evaluated the potential of dioxathion to be absorbed through the skin or to cause systemic effects following dermal exposure. Although a predictive model indicates that dioxathion has low potential to be absorbed through the skin and be systemically available, acute dermal toxicity studies in rats and rabbits [Frawley et al. 1963; Gaines 1969 ] indicate that dioxathion is absorbed through the skin, is systemically available, and can be fatal at low doses following dermal exposure. No in vitro tests, case reports or standard skin irritation tests were identified that evaluated the potential of dioxathion to produce direct effects on the skin. No diagnostic tests in humans or predictive tests in animals were identified to adequately evaluate the potential of dioxathion to cause skin sensitization. Therefore, on the basis of these assessments, dioxathion is assigned a composite skin notation of SK: SYS (FATAL). Table 3 summarizes the skin hazard designations for dioxathion previously issued by NIOSH and other organizations. The equivalent dermal designations for dioxathion, according to the Global Harmonization System (GHS) of Classification and Labelling of Chemicals, is Acute Toxicity Category 3 (Hazard statement: Toxic in contact with the skin) [European Parliament 2008] . 
Appendix: Calculation of the SI Ratio for Dioxathion
This appendix presents an overview of the SI ratio and a summary of the calculation of the SI ratio for dioxathion. Although the SI ratio is considered in the determination of a substance's hazard potential following skin contact, it is intended only to serve as supportive data during the assignment of the NIOSH SK. An in-depth discussion on the rationale and calculation of the SI ratio can be found in Appendix B of the Current Intelligence Bulletin (CIB) 61: A Strategy for Assigning New NIOSH Skin Notations [NIOSH 2009 ].
Overview
The SI ratio is a predictive algorithm for estimating and evaluating the health hazards of skin exposure to substances. The algorithm is designed to evaluate the potential for a substance to penetrate the skin and induce systemic toxicity [NIOSH 2009 ]. The goals for incorporating this algorithm into the proposed strategy for assigning SYS notation are as follows:
(1) Provide an alternative method to evaluate substances for which no clinical reports or animal toxicity studies exist or for which empirical data are insufficient to determine systemic effects. (2) Use the algorithm evaluation results to determine whether a substance poses a skin absorption hazard and should be labeled with the SYS notation.
The algorithm evaluation includes three steps:
(1) determining a skin permeation coefficient (k p ) for the substance of interest, (2) estimating substance uptake by the skin and respiratory absorption routes, and (3) evaluating whether the substance poses a skin exposure hazard.
The algorithm is flexible in the data requirement and can operate entirely on the basis of the physicochemical properties of a substance and the relevant exposure parameters. Thus, the algorithm is independent of the need for biologic data. Alternatively, it can function with both the physicochemical properties and the experimentally determined permeation coefficient when such data are available and appropriate for use.
The first step in the evaluation is to determine the k p for the substance to describe the transdermal penetration rate of the substance [NIOSH 2009 ]. The k p , which represents the overall diffusion of the substance through the stratum corneum and into the blood capillaries of the dermis, is estimated from the compound's molecular weight (MW) and base-10 logarithm of its octanol-water partition coefficient (log KOW). In this example, k p is determined for a substance with use of Equation 1. A self-consistent set of units must be used, such as centimeters per hour (cm/hr), outlined in The second step is to calculate the biologic mass uptake of the substance from skin absorption (skin dose) and inhalation (inhalation dose) during the same period of exposure. The skin dose is calculated as a mathematical product of the kp, the water solubility (SW) of the substance, the exposed skin surface area, and the duration of exposure. Its units are milligrams (mg). Assume that the skin exposure continues for 8 hours to unprotected skin on the palms of both hands (a surface area of 360 squared centimeters [cm 2 ]).
Equation 2: Determination of Skin Dose
Skin dose = k p × S w × Exposed skin surface area × Exposure time = k p (cm/hr) × S w (mg/cm 3 ) × 360 cm 2 × 8 hr
The inhalation dose (in mg) is derived on the basis of the occupational exposure limit (OEL) of the substance-if the OEL is developed to prevent the occurrence of systemic effects rather than sensory/irritant effects or direct effects on the respiratory tract. Assume a continuous exposure of 8 hours, an inhalation volume of 10 cubic meters (m 3 ) inhaled air in 8 hours, and a factor of 75% for retention of the airborne substance in the lungs during respiration (retention factor, or RF). The final step is to compare the calculated skin and inhalation doses and to present the result as a ratio of skin dose to inhalation dose (the SI ratio). This ratio quantitatively indicates (1) the significance of dermal absorption as a route of occupational exposure to the substance and (2) the contribution of dermal uptake to systemic toxicity. If a substance has an SI ratio greater than or equal to 0.1, it is considered a skin absorption hazard. Calculation Table A1 summarizes the data applied in the previously described equations to determine the SI ratio for dioxathion. The calculated SI ratio was 0.0027. On the basis of these results, dioxathion is not predicted to represent a skin absorption hazard. The OEL used in calculation of the SI ratio for dioxathion was the NIOSH recommended exposure limit (REL) [NIOSH 2005 ].
